Share chart KemPharm, Inc.
Extended chart
Simple chart
About KemPharm, Inc.
KemPharm, Inc., специализированная фармацевтическая компания, обнаруживает и разрабатывает различные запатентованные пролекарства для лечения серьезных заболеваний в США. Компания использует свою технологию терапии с активированным лигандом для создания улучшенных пролекарственных версий одобренных FDA лекарств, а также для создания пролекарственных версий существующих соединений, которые могут найти применение при новых показаниях к заболеваниям. more detailsMain settings
| IPO date | 2015-04-16 |
|---|---|
| ISIN | US4884452065 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | link |
| Change price per day: | 0% (4.97) |
|---|---|
| Change price per week: | 0% (4.97) |
| Change price per month: | 0% (4.97) |
| Change price per 3 month: | 0% (4.97) |
| Change price per half year: | 0% (4.97) |
| Change price per year: | 0% (4.97) |
| Change price per 3 year: | +8.04% (4.6) |
| Change price per 5 year: | +14.2% (4.352) |
| Change price per year to date: | 0% (4.97) |
Grade
Underestimation
| Title | Value | Grade |
|---|---|---|
| P/S | 14.15 | 1 |
| P/BV | 1.72 | 8 |
| P/E | 14.58 | 8 |
Efficiency
| Title | Value | Grade |
|---|---|---|
| ROA, % | -33.44 | 0 |
| ROE, % | -39.02 | 0 |
| ROIC, % | -16.05 | 0 |
Dividends
| Title | Value | Grade |
|---|---|---|
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
|---|---|---|
| Debt/EBITDA | -0.5851 | 10 |
| Debt/Ratio | 0.1221 | 10 |
| Debt/Equity | 0.3462 | 10 |
Growth impulse
| Title | Value | Grade |
|---|---|---|
| Yield Revenue, % | -17.69 | 0 |
| Yield Ebitda, % | -0.1467 | 0 |
| Yield EPS, % | -102.27 | 0 |
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard Group, Inc. (The) | 1 380 638 | 32 |
| Blackrock Inc. | 847 611 | 19.64 |
| HealthInvest Partners AB | 750 000 | 17.38 |
| Laurion Capital Management, LP | 571 200 | 13.24 |
| Janney Montgomery Scott LLC | 494 030 | 11.45 |
| Geode Capital Management, LLC | 304 652 | 7.06 |
| Retirement Planning Co of New England, Inc. | 297 384 | 6.89 |
| Sabby Management, LLC | 248 592 | 5.76 |
| Mystic Asset Management, Inc. | 175 883 | 4.08 |
| Millennium Management LLC | 165 303 | 3.83 |
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Commission, % |
|---|---|---|---|
| Credit Suisse S&P MLP Index ETN | 8.32 | 63.82 | 0.95 |
| 8.32 | 63.82 | 0.95 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Richard W. Pascoe | Exec. Chairman | 515.43k | 1964 (61 year) |
| Dr. Travis C. Mickle Ph.D. | Co-Founder, Pres, CEO & Director | 773.13k | 1973 (52 years) |
| Mr. R. LaDuane Clifton CPA | CFO, Sec. & Treasurer | 476.28k | 1972 (53 years) |
| Dr. Sven Guenther | Exec. VP of R&D | 497.26k | 1972 (53 years) |
| Mr. Timothy J. Sangiovanni CPA | VP & Corp. Controller | N/A | 1984 (41 year) |
| Dr. Andrew Barrett | VP of Scientific Affairs | N/A | |
| Ms. Christal M. M. Mickle M.A. | Co-Founder and Sr. VP of Operations & Product Devel. | N/A | 1979 (46 years) |
| Ms. Nichol L. Ochsner | VP of Investor Relations & Corp. Communications | N/A |
About company
Address: United States, Celebration. FL, 1180 Celebration Boulevard - Open in google maps, Open in yandex maps
Website: https://kempharm.com
Website: https://kempharm.com
